Crypto Founder Pardoned by Donald Trump Turns Focus to Biohacking
4 Articles
4 Articles
Arthur Hayes Turns to Longevity: From Derivatives to Stem Cells and DeSci
Arthur Hayes, the billionaire co-founder of BitMEX, is shifting his attention from perpetual swaps to perpetual life as the market expert targets longevity science for mega growth. Fresh off a presidential pardon by Donald Trump in March that erased his conviction for Bank Secrecy Act violations, Hayes has taken a board seat and major equity stake in a stem cell company where he has also been a patient. Hayes told reporters he has been undergoin…
Post-Pardon, Arthur Hayes Invests in Stem Cells, Eyes Longevity
In recent developments, Arthur Hayes, the former CEO of cryptocurrency exchange BitMEX, has made headlines again with a significant shift in his investment strategy. Hayes, a notable figure in the cryptocurrency space, is pivoting towards biotechnology, focusing on stem cell research investments. This strategic move comes in an effort to diversify his assets beyond the volatile cryptocurrency markets. Hayes Dives into Biotechnology Arthur Hayes,…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium